
    
      PROTOCOL OUTLINE: Participants are screened for Huntington's disease, including cerebral
      glucose metabolism assessment and genetic testing.

      Studies include a detailed family history and neurologic, psychometric, and neurobehavioral
      evaluations. Imaging includes positron emission tomography with fluorodeoxyglucose and brain
      magnetic resonance imaging.

      A genotype assessment is performed; genetic results are not disclosed to patients or
      relatives.
    
  